Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 66

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 66
---
 the terms of the 2025 Plan, no participant may be granted incentive awards covering more than 400,000 shares of common stock in any one calendar year.

All of the share limitations in the 2025 Plan may be adjusted to reflect changes in our corporate structure or shares, as described below.

Adjustments. In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, divestiture or extraordinary dividend (including a spin-off) or any other similar change in our corporate structure or shares, we must adjust:

| ● | the number and kind of securities available for issuance under the 2025 Plan; and |

| ● | in order to prevent dilution or enlargement of the rights of participants, the number, kind and, where applicable, the exercise price of securities subject to outstanding incentive awards. |

Administration. The 2025 Plan will be administered by the Board or by a committee of the Board. Any such committee will consist of at least two members of the Board, all of whom are “non-employee directors” within the meaning of Rule 16b-3 under the Exchange Act, and who are “independent directors” within the meaning of the Listing Rules of Nasdaq (or other applicable exchange or market on which our common stock may be traded or quoted). We expect the Compensation Committee of the Board to administer the 2025 Plan. The Board or the committee administering the 2025 Plan is referred to as the “committee.” The committee may delegate its duties, power and authority under the 2025 Plan to any of our officers to the extent consistent with applicable corporate law, except with respect to participants subject to Section 16 of the Exchange Act.

<div align='center'>35</div>

The committee has the authority to determine all provisions of incentive awards consistent with terms of the 2025 Plan, including, the eligible recipients who will be granted one or more incentive awards under the 2025 Plan, the nature and extent of the incentive awards to be made to each participant, the time or times when incentive awards will be granted, the duration of each incentive award, and the restrictions and other conditions to which the payment or vesting of incentive awards may be subject. The committee may amend or modify the terms of outstanding incentive awards (except for any prohibited “re-pricing” of options, discussed below) so long as the amended or modified terms are permitted under the 2025 Plan and